Hubei Goto Biopharm Co.,Ltd. (SHE:300966)

China · Delayed Price · Currency is CNY

20.75

+0.93 (4.69%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Self-Produced	427.81M	394.89M	441.80M	472.41M	384.35M
Self-Produced Growth	8.34%	-10.62%	-6.48%	22.91%	-1.77%
Non-Self Produced	108.79M	171.51M	162.77M	118.48M	83.77M
Non-Self Produced Growth	-36.57%	5.37%	37.39%	41.43%	13.93%
Total	536.60M	566.40M	604.57M	590.89M	468.12M
Total Growth	-5.26%	-6.31%	2.32%	26.23%	0.71%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	383.44M	437.53M	506.67M	517.14M	421.31M
China Growth	-12.36%	-13.65%	-2.02%	22.75%	4.27%
Overseas	153.16M	128.87M	97.91M	73.75M	46.81M
Overseas Growth	18.85%	31.62%	32.75%	57.55%	-22.93%
Total	536.60M	566.40M	604.57M	590.89M	468.12M
Total Growth	-5.26%	-6.31%	2.32%	26.23%	0.71%

Source: S&P Global Market Intelligence.